12/27/22 Health Advisory: Updated bivalent COVID-19 boosters authorized for children 6 months to 5 years old

Earlier this month, U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) expanded emergency use authorization (EUA) of Moderna and Pfizer-BioNTech bivalent vaccines for children 6 months and older. Updated (bivalent) COVID-19 booster vaccines are formulated to boost immunity against the original coronavirus strain and protect against the newer omicron … 12/27/22 Health Advisory: Updated bivalent COVID-19 boosters authorized for children 6 months to 5 years old